Age-related changes in pericellular hyaluronan organization leads to impaired dermal fibroblast to myofibroblast differentiation

American Journal of Pathology

Volumn 175, Issue 5, 2009, Pages 1915-1928

  Simpson, Russell M L ^a   Meran, Soma ^a   Thomas, David ^a   Stephens, Philip ^a   Bowen, Timothy ^a   Steadman, Robert ^a   Phillips, Aled ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; HYALURONIC ACID; HYALURONIDASE; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA1;

AGE DISTRIBUTION; AGED; AGING; ARTICLE; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; ENZYME INHIBITION; GENE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CELL; TUMOR NECROSIS FACTOR ALPHA STIMULATED GENE 6; WOUND HEALING;

EID: 73649131572     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090045     Document Type: Article

References (50)

1. Ashcroft GS, Mills SJ, Ashworth JJ: Aging and wound healing. Biogerontology 2002, 3:337-345
2. Ashcroft GS, Roberts AB: Loss of Smad3 modulates wound healing. Cytokine Growth Factor Rev 2000, 11:125-131
3. Gabbiani G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003, 200:500-503
4. Desmoulière A, Darby IA, Gabbiani G: Normal and pathologic soft tissue remodeling: the role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 2003, 83:1689-1707
5. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349-363
6. Eddy AA: Progression in chronic kidney disease. Adv Chronic Kidney Dis 2005, 12:353-365
7. Schuppan D, Koda M, Bauer M, Hahn EG: Fibrosis of liver, pancreas and intestine: common mechanisms and clear targets? Acta Gastroenterol Belg 2000, 63:366-370
8. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993, 122:103-111
9. Evans RA, Tian YC, Steadman R, Phillips AO: TGF-β1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp Cell Res 2003, 282:90-100
10. Mogford JE, Tawil N, Chen A, Gies D, Xia Y, Mustoe TA: Effect of age and hypoxia on TGFβ1 receptor expression and signal transduction in human dermal fibroblasts: Impact on cell migration. Cell Physiol 2002, 190:259-265
11. Spicer AP, Kaback LA, Smith TJ, Seldin MF: Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes. J Biol Chem 1998, 271:25117-15124
12. Spicer AP, McDonald JA: Characterisation and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem 1998, 272:1923-1932
13. Kosaki R, Watanabe K, Yamaguchi Y: Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage independent growth. Cancer Res 1999, 59:1141-1145
14. Itano N, Atsumi F, Sawai T, Yamada Y, Miyaishi O, Senga T, Hamaguchi M, Kimata K: Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci USA 2002; 99:3609-3614
15. Ito T, Williams JD, Al-Assaf S, Phillips GO, Phillips AO: Hyaluronan and proximal tubular epithelial cell migration. Kidney Int 2004, 65:823-833
16. Legg JW, Lewis CA, Parsons M, Ng T, Isacke CM: A novel PKC-regulated mechanism controls CD44 ezrin association and directional cell motility. Nat Cell Biol 2002, 4:399-407
17. Zoltan-Jones A, Huang L, Ghatak S, Toole BP: Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem 2003, 278:45801-45810
18. Brecht M, Mayer U, Schlosser E, Prehm P: Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J 1986, 239:445-450
19. Evanko SP, Angello JC, Wight TN: Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999, 19:1004-1013
20. Ito T, Williams JD, Fraser DJ, Phillips AO: Hyaluronan attenuates TGF-β1 mediated signalling in renal proximal tubular epithelial cells. Am J Pathol 2004, 164:1979-1988
21. Ito T, Williams JD, Fraser DJ, Phillips AO: Hyaluronan regulates TGF-β1 receptor compartmentalization. J Biol Chem 2004, 279:25326-25332
22. Jenkins RH, Thomas GJ, Williams JD, Steadman R: Myofibroblastic differentiation leads to hyaluronan accumulation through reduced hyaluronan turnover. J Biol Chem 2004, 279:41453-41460
23. Meran S, Thomas D, Stephens P, Martin J, Bowen T, Phillips A, Steadman R: Involvement of hyaluronan in regulation of fibroblast phenotype. J Biol Chem 2007, 282:25687-25697
24. Meran S, Thomas DW, Stephens P, Enoch S, Martin J, Steadman R, Phillips AO: Hyaluronan facilitates transforming growth factor-β1-mediated fibroblast proliferation. J Biol Chem 2008, 283:6530-6545
25. Vigetti D, Viola M, Karousou E, Rizzi M, Moretto P, Genasetti A, Clerici M, Hascall VC, De Luca G, Passi A: Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging. J Biol Chem 2008, 283:4448-4458
26. Vigetti D, Moretto P, Viola M, Genasetti A, Rizzi M, Karousou E, Pallotti F, De Luca G, Passi A: Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging. FASEB J 2006, 20:1118-1130
27. Shiraha H, Gupta K, Drabik K, Wells A: Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. J Biol Chem 2000, 275:19343-19351
28. Ashcroft GS, Horan MA, Ferguson MW: The effects of aging on cutaneous wound healing in mammals. J Anat 1995, 187:1-26
29. Stephens P, Davies KJ, Occleston N, Pleass RD, Kon C, Daniels J, Khaw PT, Thomas DW: Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase activity. Br Journal Dermatol 2001, 144:229-237
30. Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC: Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci USA 1998, 95:10614-10619
31. Fülöp C, Szanto S, Mukhopadhyay D, Bardos T, Kamath RV, Rugg MS, Day AJ, Salustri A, Hascall VC, Glant TT, Mikecz K: Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice. Development 2003, 130:2253-2261
32. Rugg MS, Willis AC, Mukhopadhyay D, Hascall VC, Fries E, Fülöp C, Milner CM, Day AJ: Characterization of complexes formed between TSG-6 and inter-α-inhibitor that act as intermediates in the covalent transfer of heavy chains on to hyaluronan. J Biol Chem 2005, 280:25674-25686
33. Selbi W, Day AJ, Rugg MS, Fülöp C, de la Motte CA, Bowen T, Hascall VC, Phillips AO: Overexpression of hyaluronan synthase 2 alters hyaluronan distribution and function in proximal tubular epithelial cells. J Am Soc Nephrol 2006, 17:1553-1567
34. Oertli B, Fan X, Wüthrich RP: Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells. Nephrol Dial Transplant 1998, 13:271-278
35. Lüke HJ, Prehm P: Synthesis and shedding of hyaluronan from plasma membranes of human fibroblasts and metastatic and non-metastatic melanoma cells. Biochem J 1999, 343:71-75
36. Tammi R, MacCallum D, Hascall VC, Pieninäkit JP, Hyttinen M, Yammi M: Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides. J Biol Chem 1998, 273:28878-28888
37. Nandi A, Esress P, Siegelman MH: Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44. J Biol Chem 2000, 275:14939-14948
38. Heldin P, Pertoft H: Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. Exp Cell Res 1993, 208:422-429
39. Lesley J, Hascall VC, Tammi M, Hyman R: Hyaluronan binding by cell surface CD44. J Biol Chem 2000, 275:26967-26975
40. Ashcroft GS, Horan MA, Ferguson MW: Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest 1998, 78:47-58
41. Pieraggi MJ, Bouissou H, Angelier C, Uhart D, Magnol J, Kokolo J: Le fibroblaste. Ann Pathol 1985, 5:65-76
42. Bruce SA, Deamond SF: Longitudinal study of in vivo wound repair and in vitro cellular senescence of dermal fibroblasts. Exp Gerontol 1991, 26:17-27
43. Muggleton-Harris AL, Reisert PS, Burghoff RL: In vitro characterization of response to stimulus (wounding) with regard to aging in human skin fibroblasts. Mech Aging Dev 1982, 19:37-43
44. Matrisian LM, Davis D, Magun BE: Internalization and processing of epidermal growth factor in aging human fibroblasts in culture. Exp Gerontol 1987, 22:81-89
45. Rattan SI, Derventzi A: Altered cellular responsiveness during aging. BioEssays 1991, 13:601-601
46. Bedossa P, Paradis V: Liver extracellular matrix in health and disease. J Pathol 2003, 200:504-515
47. Chapman HA: Disorders of lung matrix remodeling. J Clin Invest 2004, 113:148-157
48. Eddy AA: Molecular basis of renal fibrosis. Pediatr Nephrol 2000, 15:290-301
49. Francis GS, McDonald K, Chu C, Cohn JN: Pathophysiologic aspects of end-stage heart failure. Am J Cardiol 1995, 75:11A-16A
50. Green FHY: Overview of pulmonary fibrosis. Chest 2002, 122: 334S-339S